Medical Disclaimer
The content on GLPSurgery.com is provided for general educational purposes only. It is not medical advice, does not establish a clinician–patient relationship, and is not a substitute for evaluation by a licensed healthcare professional.
No medical advice
Information on this website — including articles, comparisons, FAQs, and decision-support content — is general in nature. It does not take into account any individual's medical history, diagnoses, medications, allergies, or personal circumstances. Reading content on this site does not create a clinician–patient relationship between the reader and any author, reviewer, organization, or affiliated entity.
Always consult a qualified clinician
Decisions about starting, changing, continuing, or stopping any medication — including GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) — and decisions about whether bariatric, metabolic, or endoscopic procedures are appropriate should be made together with a licensed physician who has reviewed your full medical history. If you are experiencing a medical emergency, call your local emergency number.
No guarantees of outcomes
Individual results vary. GLPSurgery.com does not guarantee any specific clinical outcome, weight change, metabolic improvement, durability of effect, or absence of adverse events. Treatment options described on this site carry potential benefits and potential risks that should be discussed with a qualified clinician.
Regulatory status of treatments described
Discussion of any medication or procedure on this site is educational and does not constitute promotion. References to specific medications use the United States Adopted Names and trade names. Regulatory approval, labeled indications, and access may differ by country and may change over time.
External links
GLPSurgery.com may link to external websites for educational reference. Inclusion of a link does not constitute endorsement of the linked organization, its providers, or any opinions expressed there. We are not responsible for the content of external sites.
Updates to this disclaimer
We may update this disclaimer from time to time. Material changes will be reflected by an updated "Last reviewed" date on this page.
Dr. Ariel Ortiz Lagardere, MD, FACS, FASMBS
Bariatric & Metabolic Surgeon · Founder, Obesity Control Center
Last reviewed: June 2026
Educational claims on this page are supported by independent guidelines, peer-reviewed evidence, and verifiable accreditation listings. See Sources & Verification and Science & Evidence.
Medical notice. This content is educational only and does not replace professional medical advice. Do not start, stop, or change GLP-1 medication without consulting your physician.